| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Anatomy, University of Connecticut Health Center Farmington, Connecticut 06030
Address requests for reprints to: Dr. Bruce A. White, Department of Anatomy, University of Connecticut Health Center, Farmington, Connecticut 06030.
Abstract
Transforming growth factor-β (TGFβ) is a member of a large family of growth factors, several of which regulate pituitary function. TGFβ has recently been reported to reduce PRL production by GH4 cells. We have examined the effect of TGFβ on PRL gene expression in rat pituitary tumor GH3 cells. TGFβ1 or TGFβ2 reduced both basal and Ca2+-stimulated PRL mRNA levels. This inhibition was specific, as the mRNA levels for GH, glucose-regulated protein 78, and histone-3 were unaffected by TGFβ. Inhibition of PRL gene expression by TGFβ was dose dependent in the range of 0.5–10 ng/ml. TGFβ inhibited runon PRL gene transcription in nuclei from treated cells to the same extent that it reduced PRL mRNA levels, indicating a transcriptional mechanism of action. However, TGFβ did not affect Pit-1 mRNA levels or run-on transcription of the Pit-1 gene. Thus, TGFβ does not appear to act through modification of Pit-1 gene expression. The PRL promotor contains two regions of homology, with a consensus sequence found in the promotors of other TGFβ-inhibited genes. These findings are consistent with other studies that have demonstrated transcriptional repression by TGFβ. The potency and specificity of the effects of TGFβ on PRL gene expression suggest that it may be a physiological regulator of lactotroph function.
FOOTNOTES
This work was supported by NIH Research Grant DK-43064.
Received for publication May 22, 1991. Revision received August 21, 1991. Accepted for publication September 4, 1991.
This article has been cited by other articles:
![]() |
D. Giacomini, M. Paez-Pereda, J. Stalla, G. K. Stalla, and E. Arzt Molecular Interaction of BMP-4, TGF-{beta}, and Estrogens in Lactotrophs: Impact on the PRL Promoter Mol. Endocrinol., July 1, 2009; 23(7): 1102 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sowa, H. Kaji, R. Kitazawa, S. Kitazawa, T. Tsukamoto, S. Yano, T. Tsukada, L. Canaff, G. N. Hendy, T. Sugimoto, et al. Menin Inactivation Leads to Loss of Transforming Growth Factor {beta} Inhibition of Parathyroid Cell Proliferation and Parathyroid Hormone Secretion Cancer Res., March 15, 2004; 64(6): 2222 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paez-Pereda, D. Giacomini, D. Refojo, A. C. Nagashima, U. Hopfner, Y. Grubler, A. Chervin, V. Goldberg, R. Goya, S. T. Hentges, et al. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk PNAS, February 4, 2003; 100(3): 1034 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Renner, P. Lohrer, L. Schaaf, M. Feirer, K. Schmitt, C. Onofri, E. Arzt, and G. K. Stalla Transforming Growth Factor-{beta} Stimulates Vascular Endothelial Growth Factor Production by Folliculostellate Pituitary Cells Endocrinology, October 1, 2002; 143(10): 3759 - 3765. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. MacConell, A. M. O. Leal, and W. W. Vale The Distribution of Betaglycan Protein and mRNA in Rat Brain, Pituitary, and Gonads: Implications for a Role for Betaglycan in Inhibin-Mediated Reproductive Functions Endocrinology, March 1, 2002; 143(3): 1066 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oka, L. Jin, E. Kulig, B. W. Scheithauer, and R. V. Lloyd Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Transforming Growth Factor-{beta}1-Induced Apoptosis in a Human Pituitary Adenoma Cell Line Am. J. Pathol., December 1, 1999; 155(6): 1893 - 1900. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Abraham, W. J. Faught, and L. S. Frawley Transforming Growth Factor {beta}1 Is a Paracrine Inhibitor of Prolactin Gene Expression Endocrinology, December 1, 1998; 139(12): 5174 - 5181. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sarkar, M. Pastorcic, A. De, M. Engel, H. Moses, and M. B. Ghasemzadeh Role of Transforming Growth Factor (TGF)-{beta} Type I and TGF-{beta} Type II Receptors in the TGF-{beta}1-Regulated Gene Expression in Pituitary Prolactin-Secreting Lactotropes Endocrinology, August 1, 1998; 139(8): 3620 - 3628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chuang, S.-K. Tan, L.-K. Tai, J.-P. Hsin, and F.-F. Wang Evidence for the Involvement of Protein Kinase C in the Inhibition of Prolactin Gene Expression by Transforming Growth Factor-beta 2 Mol. Pharmacol., June 1, 1998; 53(6): 1054 - 1061. [Abstract] [Full Text] |
||||
![]() |
D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text] |
||||
![]() |
S.-K. Tan, F.-F. Wang, H.-F. Pu, and T.-C. Liu Differential Effect of Age on Transforming Growth Factor-{beta}1 Inhibition of Prolactin Gene Expression Versus Secretion in Rat Anterior Pituitary Cells Endocrinology, March 1, 1997; 138(3): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |